2417369-94-7 (PROTAC ERα Degrader-1,PROTAC ERα Degrader-1)

PROTAC ERα Degrader-1;PROTAC ERalpha Degrader-1;PROTAC ER;A Degrader-1;4-[(3S,4S)-7-cyano-1-[(2-methoxynaphthalen-1-yl)methyl]-4-methyl-3-[[(2S)-2-(methylamino)propanoyl]amino]-2-oxo-3,4-dihydro-1,5-benzodiazepine-5-carbonyl]-N-[2-[2-[2-[2-[4-[(Z)-1-(4-hydroxyphenyl)-2-phenylbut-1-enyl]phenoxy]ethyl-methylamino]-2-oxoethoxy]ethoxy]ethyl]benzamide;2417369-94-7;SCHEMBL19616620;AKOS037653373;EX-A8715;T18636;HY-112098;CS-0043343;G17163;

SNBOCOFSYPHJLP-XJQCFLMPSA-N

1S/C66H69N7O10/c1-7-54(46-13-9-8-10-14-46)61(48-22-27-52(74)28-23-48)49-24-29-53(30-25-49)83-36-34-71(5)60(75)42-82-38-37-81-35-33-69-64(77)50-18-20-51(21-19-50)65(78)73-44(3)62(70-63(76)43(2)68-4)66(79)72(57-31-17-45(40-67)39-58(57)73)41-56-55-16-12-11-15-47(55)26-32-59(56)80-6/h8-32,39,43-44,62,68,74H,7,33-38,41-42H2,1-6H3,(H,69,77)(H,70,76)/b61-54-/t43-,44-,62-/m0/s1

O=C1[C@]([H])([C@]([H])(C([H])([H])[H])N(C(C2C([H])=C([H])C(C(N([H])C([H])([H])C([H])([H])OC([H])([H])C([H])([H])OC([H])([H])C(N(C([H])([H])[H])C([H])([H])C([H])([H])OC3C([H])=C([H])C(=C([H])C=3[H])/C(/C3C([H])=C([H])C(=C([H])C=3[H])O[H])=C(\C3C([H])=C([H])C([H])=C([H])C=3[H])/C([H])([H])C([H])([H])[H])=O)=O)=C([H])C=2[H])=O)C2C([H])=C(C#N)C([H])=C([H])C=2N1C([H])([H])C1=C(C([H])=C([H])C2=C([H])C([H])=C([H])C([H])=C12)OC([H])([H])[H])N([H])C([C@]([H])(C([H])([H])[H])N([H])C([H])([H])[H])=O